ArticleInternational journal of ophthalmology2025
Combination of red blood cell distribution width and platelet-to-lymphocyte ratio for predicting severity of diabetic retinopathy.
Article in International journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Potential Molecular Biomarkers for Predicting and Monitoring Complications in Type 2 Diabetes Mellitus.Molecules (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo assess and compare the utility of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic inflammation index (SII), and red blood cell distribution width (RDW) as potential biomarkers to predict the severity of diabetic retinopathy (DR) in the United States population.
methodsThe observational study enlisted patients diagnosed with DR from the National Health and Nutrition Examination Survey (NHANES) database, spanning the period from 2005 to 2008. The severity of DR was defined according to Early Treatment for Diabetic Retinopathy Study (ETDRs). The effect of NLR, PLR, SII, and RDW on proliferative diabetic retinopathy (PDR) were explored using multivariable logistic regression analysis model. Subgroup analysis and restricted cubic splines (RCS) were conducted to assess the robustness of the correlations across subgroups and to explore nonlinear relationships between four indices and PDR. The receiver operating characteristic (ROC) analysis was employed for the purpose of assessing and evaluating the predictive efficacy of NLR, PLR, SII, and RDW in determining the severity of DR.
resultsAfter adjusting for other confounders (age, gender, race, body mass index, diabetes duration, and HbA1c) in multivariable analysis, a unit increase of PLR×0.1, SII×0.01, and RDW would raise the risk for PDR by 15.6%, 22.2%, and 33%, respectively. Particularly, there was a 2.208-fold greater risk of PDR in individuals with an elevated NLR (OR=2.208, 95%CI, 1.348-3.617,
conclusionThe combination of RDW and NLR demonstrates a promising ability to predict the severity of DR across the United States population, and it could be promisingly used in clinics for monitoring the progress of DR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.